Immune Thrombocytopenia: Are We Stuck in the Mud or Is There Light at the End of the Tunnel? James BusselOriana Miltiadous Perspective Open access 12 August 2019 Pages: 173 - 179
Managing Endocrine Disorders in Adults After Hematopoietic Stem Cell Transplantation Juliana MatthewsDwight EplinLeslee Matheny Review Open access 24 September 2019 Pages: 180 - 188
Moving Toward Continuous Therapy in Multiple Myeloma Francesca BonelloGiusy CetaniAlessandra Larocca Review Open access 12 November 2019 Pages: 189 - 200
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation Zachariah DeFilippNalu Navarro-AlvarezChristene A. Huang Research Article Open access 29 August 2019 Pages: 201 - 204
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma Lalit KumarSantosh Kumar ChellapuramAIIMS Myeloma Group Research Article Open access 23 August 2019 Pages: 205 - 219
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study Agoston Gyula SzaboKatrine Fladeland IversenTorben Plesner Research Article Open access 12 August 2019 Pages: 220 - 228
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation Dwight D. EplinAnna D. JacksonBipin N. Savani Research Article Open access 14 October 2019 Pages: 229 - 233